StockData
Cronos Group Inc. logo

Cronos Group Inc. (CRON) stock

CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.19−0.08 (-2.45%)

Close on Nov 17, 2026Market cap $1.18BP/E 15.9Yield –

Cronos price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cronos's price to sales ratio was 7.1× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 5.9× to 22.6×, with a median of 8.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.1×−0.5
2025Dec 31, 20257.6×+0.7
2024Dec 31, 20246.9×−2.4
2023Dec 29, 20239.3×−2.3
2022Dec 30, 202211.6×−10.7
2021Dec 31, 202122.3×−46.6
2020Dec 31, 202068.9×−348.0
2018Oct 31, 2018416.8×–

More Cronos figures

See a number that looks wrong?